FDA grants EUA for Russia's Sputnik V vaccine

The Food and Drug Administration (FDA) granted an emergency use authorization for Russia's Sputnik V vaccine.

Carlito Galvez Jr., chief implementer of the National Task Force Against Covid-19, announced that the government will order around three million doses of the vaccine for delivery in April or May.

Negotiations are also underway to allow local government units and private firms to procure the Sputnik V vaccine.

The FDA's approval follows a late-stage trial showing 91.6% efficacy for the two-dose vaccine, which is now available for individuals aged 18 years and older.